Small But Mighty Sinus Implant

PROPEL Mini, a smaller version of PROPEL, offers the same drug dose and clinical benefits as PROPEL. Physicians can now offer localized drug delivery to patients undergoing frontal sinus surgery with less extensive surgery and smaller anatomy, allowing more sinus sufferers to benefit from the only products in sinus surgery backed by Level 1-A evidence which improves sinus surgery outcomes.1

Small But Mighty Sinus Implant

PROPEL Mini, a smaller version of PROPEL, offers the same drug dose and clinical benefits as PROPEL. Physicians can now offer localized drug delivery to patients undergoing frontal sinus surgery with less extensive surgery and smaller anatomy, allowing more sinus sufferers to benefit from the only products in sinus surgery backed by Level 1-A evidence which improves sinus surgery outcomes.1

PROPEL Mini Mometasone Furoate Dissolvable Sinus Implant Logo

PROPEL Mini is the first and only product clinically proven to improve frontal sinus surgery outcomes.2 Its lower profile and curved delivery system offer precise, consistent, and easy placement.

The PROPEL Mini sinus implant is intended for use in patients ≥ 18 years of age following ethmoid/frontal sinus surgery to maintain patency of the ethmoid sinus or frontal sinus opening. The PROPEL Mini sinus implant separates/dilates surrounding mucosal tissues, provides stabilization of the middle turbinate, prevents obstruction by adhesions, and reduces inflammation. The implant reduces the need for post-operative intervention such as surgical adhesion lysis and/or use of oral steroids.

The PROPEL Mini dissolvable sinus implant props the frontal or ethmoid sinus open while releasing an advanced corticosteroid (mometasone furoate) directly to the sinus over 30 days post-surgery. Results show that PROPEL Mini is superior to surgery alone, reducing the need for oral steroids and additional surgical procedures.3,4

PROGRESS Study:
PROPEL Mini Maintains Frontal Sinus Opening Following Sinus Surgery

PROGRESS Study: An 80-patient prospective, randomized, blinded, controlled trial evaluated outcomes of frontal sinus surgery using balloons and/or traditional instruments with PROPEL Mini compared to the standard care, surgery alone.2

Contraindications include patients with intolerance to mometasone furoate (MF) or a hypersensitivity to bioabsorbable polymers. Safety and effectiveness of the implants in pregnant or nursing females have not been studied. Risks may include, but are not limited to, pain/pressure, displacement of implant, possible side effects of intranasal MF, sinusitis, epistaxis, and infection. Rx Only.

PROPEL Mini Progress Study - Surgery with PROPEL Mini Sinus Implant vs Surgery Alone

PROPEL Mini Sinus Implant Product Details

  • Indicated for the Ethmoid and Frontal Sinuses
  • Same Drug Dose and Elution Profile as PROPEL
  • 16mm Nominal Length
U.S. Instructions for Use
EU Instructions for Use
PROPEL Mini Dissolvable Sinus Stent Product Photo

Learn More About
PROPEL Sinus Implants

We have compiled resources to help physicians and patients better understand how the PROPEL steroid-releasing implant works to improve sinus surgery outcomes.

Physician Resources
Patient Resources

1Han JK, Marple BF, Smith TL, et al. Int Forum Allergy Rhinol. 2012; 2:271-279.
2Smith T, Singh A, et al. Laryngoscope. 2016.
3Kennedy DW, Wright ED, Goldberg AN. Laryngoscope. 2000; 110(S94):29-31.
4Kennedy DW. Expert Review of Respiratory Medicine. 2012; 6(5):493-498.

The above-identified implants, delivery systems, and/or the use of the above-identified implants/delivery systems in a method may be covered by one or more U.S. and/or foreign patents, found at intersectent.com/patents